Keegan Cooke - Oncol Therapeut Area, Amgen Inc

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 79 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

AMG 509 (xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate Cancer

Cancer discoveryno. 1 (2024): 90-103

Cited0Views0WOSBibtex

Supplementary Figure S4 from AMG 509 (xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate Cancer

Olivier Nolan-Stevaux, Cong Li,Lingming Liang,Jinghui Zhan, Juan Estrada,Tao Osgood,Fei Li, Hanzhi Zhang,Ryan Case,Christopher M. Murawsky,Bram Estes,Gregory L. Moore,Matthew J. Bernett,Umesh Muchhal, Saroja Ramanujan, Binnaz K. Staley,Jennitte Stevens,Keegan S. Cooke,Famke Aeffner, Thomas Oliver,Julia Stieglmaier, Jae‐Lyun Lee, Angela Coxon,Julie M. Bailis

openalex

Cited0Views0Bibtex

Supplementary Figure S1 from AMG 509 (xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate Cancer

Olivier Nolan-Stevaux, Cong Li,Lingming Liang,Jinghui Zhan, Juan Estrada,Tao Osgood,Fei Li, Hanzhi Zhang,Ryan Case,Christopher M. Murawsky,Bram Estes,Gregory L. Moore,Matthew J. Bernett,Umesh Muchhal, Saroja Ramanujan, Binnaz K. Staley,Jennitte Stevens,Keegan S. Cooke,Famke Aeffner,Thomas Oliver,Julia Stieglmaier, Jae‐Lyun Lee, Angela Coxon,Julie M. Bailis

openalex（2024）

Cited0Views0Bibtex

Supplementary Figure S3 from AMG 509 (xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate Cancer

Olivier Nolan-Stevaux, Cong Li, Lingming Liang,Jinghui Zhan, Juan Estrada,Tao Osgood,Fei Li, Hanzhi Zhang,Ryan Case,Christopher M. Murawsky,Bram Estes, Gregory L. Moore,Matthew J. Bernett,Umesh Muchhal,John R. Desjarlais, Binnaz K. Staley,Jennitte Stevens,Keegan S. Cooke,Famke Aeffner,Oliver Thomas,Julia Stieglmaier,Jae-Lyun Lee, Angela Coxon,Julie M. Bailis

openalex（2024）

Cited0Views0Bibtex

Supplementary Table S3 from AMG 509 (xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate Cancer

Olivier Nolan-Stevaux, Cong Li,Lingming Liang,Jinghui Zhan, Juan Estrada,Tao Osgood, Fei Li, Hanzhi Zhang,Ryan Case,Christopher M. Murawsky,Bram Estes,Gregory L. Moore,Matthew J. Bernett,Umesh Muchhal,John R. Desjarlais, Binnaz K. Staley,Jennitte Stevens,Keegan S. Cooke,Famke Aeffner, Oliver Thomas,Julia Stieglmaier,Jae-Lyun Lee, Angela Coxon,Julie M. Bailis

openalex（2024）

Cited0Views0Bibtex

Supplementary Methods from AMG 509 (xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate Cancer

Olivier Nolan-Stevaux, Cong Li,Lingming Liang,Jinghui Zhan, Juan Estrada,Tao Osgood, Fei Li, Hanzhi Zhang,Ryan Case,Christopher M. Murawsky,Bram Estes,Gregory L. Moore,Matthew J. Bernett,Umesh Muchhal,John R. Desjarlais, Binnaz K. Staley,Jennitte Stevens,Keegan S. Cooke,Famke Aeffner, Oliver Thomas,Julia Stieglmaier,Jae-Lyun Lee, Angela Coxon,Julie M. Bailis

openalex（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn